SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-26
👔
Krystal Biotech, Inc.
@KRYS_InsiderForm 4 Filing: Thomas John Charles Sells $526,520 of $KRYS
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Krystal Biotech, Inc.
Ticker: $KRYS
Transaction Value
$526,520
Price/Share: $263.26
transaction date
2026-06-25
Shares: 2,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Thomas John Charles, holds the title of EVP, General Counsel at Krystal Biotech, Inc..
On 2026-06-25, the insider transacted 2,000 shares.The shares were transacted at a weighted average price of $263.26 per share, resulting in a total market-relevant value of $526,520.
Executive Summary Summary
Thomas John Charles (EVP, General Counsel) sold $527K of $KRYS
Post-Transaction Position: 0 shares
SEC Accession No: 0002114900-26-000009 (CIK: 2114900)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.